Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation

Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation
复制标题

DOI:
10.1073/pnas.0602331103
复制
发表时间:
2006-09-19
影响因子:
11.1
通讯作者:
Uchida, Shinichi
Uchida, Shinichi
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Sohara, Eisei;Rai, Tatemitsu;Uchida, Shinichi

文献摘要

被引文献

相似文献

水通道蛋白2 (AQP2) C端框架移位突变导致常染色体显性肾源性尿崩症(AD-NDI)。为了在体内确定这种疾病的分子机制并测试可能的治疗策略,我们产生了AQP2 (763-772 del)敲入突变小鼠。杂合子敲入小鼠的尿浓缩能力严重受损。然而,他们能够在脱水后稍微增加尿液渗透压。与常染色体隐性NDI相比,这种温和的表型是人类AD-NDI的一个特征,因此表明AD-NDI小鼠模型的成功建立。AD-NDI小鼠收集管细胞的免疫荧光显示,AQP2突变体被错选到基底外侧,而不是顶端质膜。此外,突变体AQP2与野生型AQP2形成异聚物,即使在脱水条件下,对野生型AQP2的正常顶端分选也表现出显性负向影响。使用这种敲入小鼠,我们测试了几种治疗AD-NDI的药物,发现罗利普兰(一种磷酸二酯酶4抑制剂)能够增加尿液渗透压。因此,磷酸二酯酶抑制剂可能是治疗AD-NDI的有用药物。该动物模型表明,突变单体获得显性负作用,逆转了多聚体的正常极化分选。
Frame-shift mutations within the C terminus of aquaporin 2 (AQP2) cause autosomal-dominant nephrogenic diabetes insipidus (AD-NDI). To identify the molecular mechanism(s) of this disease in vivo and to test possible therapeutic strategies, we generated a mutant AQP2 (763-772 del) knockin mouse. Heterozygous knockin mice showed a severely impaired urine-concentrating ability. However, they were able to slightly increase urine osmolality after dehydration. This milder phenotype, when compared with autosomal-recessive NDI, is a feature of AD-NDI in humans, thus suggesting successful establishment of an AD-NDI mouse model. lmmunofluorescence of collecting duct cells in the AD-NDI mouse revealed that the mutant AQP2 was missorted to the basolateral instead of apical plasma membrane. Furthermore, the mutant AQP2 formed a heterooligomer with wild-type AQP2 and showed a dominant-negative effect on the normal apical sorting of wild-type AQP2 even under dehydration. Using this knockin mouse, we tested several drugs for treatment of AD-NDI and found that rolipram, a phosphodiesterase 4 inhibitor, was able to increase urine osmolality. Phosphodiesterase inhibitors may thus be useful drugs for the treatment of AD-NDI This animal model demonstrates that a mutant monomer gains a dominant-negative effect that reverses the normal polarized sorting of multimers.